Shattuck Labs Inc (STTK) Stock Analysis

Shattuck Labs Inc (STTK) is a publicly traded company in the HEALTHCARE sector. It trades at $4.87, carries a market capitalization of $433.25M. This page summarizes the public market data, fundamentals, and frequently asked questions for STTK, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

Market Sentiment

Shattuck Labs Inc currently has a Bullish sentiment score of 0.20.

About Shattuck Labs Inc

Shattuck Labs, Inc. is a clinical-stage biotechnology company based in Austin, Texas, focused on advancing innovative therapies for cancer and autoimmune diseases. Leveraging its proprietary technology platforms, the company is dedicated to developing targeted treatments aimed at addressing significant unmet medical needs. With a strong commitment to research and development, Shattuck Labs is positioned to make impactful contributions to the biopharmaceutical industry, aiming to improve patie...

GNG Research Analysis

GNG Research scores Shattuck Labs Inc (STTK) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for STTK.

Frequently Asked Questions

Does STTK pay dividends?

Shattuck Labs Inc (STTK) does not currently pay a regular dividend.

What is STTK's market cap?

Shattuck Labs Inc (STTK) has a market capitalization of $433.25M with a current stock price of $4.87.